April 2017: The Research Advocate

Research!America

The April 2017 Research Advocate is now online.

Highlights from this month include:

Honorees at Research!America’s 21st Annual Advocacy Awards Dinner on Wednesday, March 15 in Washington, D.C. exemplify the steadfast commitment of advocates for research in defeating disease and strengthening our nation’s preeminence in science and innovation. For a special insert of the 2017 Advocacy Awards dinner and honorees, click here

Medical research not only benefits the health of individuals, it benefits communities and the local economy, said Rep. David McKinley (R-WV-01) during Research!America’s 28th Annual Meeting of Members on Wednesday, March 15 in Washington, D.C. “We know that the NIH supports over 400,000 jobs across America. Every year NIH writes grants for [scientists and institutions across the country]. That’s significant.”

On Saturday, April 22, the March for Science will take place in more than 400 cities across the globe to celebrate the many scientific advances that have improved the health and well-being of people worldwide.

A member spotlight featuring the Lung Cancer Alliance (LCA), the leading and highest rated nonprofit organization dedicated to fighting lung cancer in the nation.

Proposed budget cuts to medical research have raised concerns among cancer research advocates who participated in the American Association of Cancer Research Annual Meeting on April 3. The policy session’s keynote speaker Joe Biden, 47th Vice President of the United States, said it’s time to double down on research, not undercut progress.

Opioid addiction, lung disease, asthma and prostate cancer research are among those being recognized with The Clinical Research Forum's Top Ten Clinical Research Achievement Awards. This year’s award ceremony will be held on Tuesday, April 18 at the National Press Club in Washington, D.C.

Through medical innovation, fatal diseases like HIV are now manageable, chronic conditions, vaccines are preventing childhood illnesses, and immunotherapies are helping to fight cancer, said Pfizer CEO Ian Read during a March 23 luncheon at the National Press Club.

Download the entire April 2017 Research Advocate as a PDF. 

 

 

Add comment

Plain text

  • No HTML tags allowed.
  • Adds node titles to internal links found in content (as HTML "title" attribute).
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana